Tetiana V. Nikolaienko

Tetiana V. Nikolaienko

Auto-generated profile, based on publicly available information

Tetiana V. Nikolaienko

Institute of Biology, Taras Shevchenko National University of Kyiv, Kyiv/Ukraine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
OBOleg Babii
Oleg Babii
SASergiy Afonin
Sergiy Afonin
LGLiudmyla V. Garmanchuk
Liudmyla V. Garmanchuk
VNViktoria V. Nikulina
Viktoria V. Nikulina
TNTetiana V. Nikolaienko
Tetiana V. Nikolaienko
IKIgor V. Komarov
Igor V. Komarov


31 August 2016 in The Ukrainian Biochemical Journal
Verified
Journal Article
Open access
TNT. V. Nikolaienko
T. V. Nikolaienko
VNV. V. Nikulina
V. V. Nikulina
DSD. V. Shelest
D. V. Shelest
LGLiudmyla V. Garmanchuk
Liudmyla V. Garmanchuk
The mechanisms of VEGF-mediated effects on endothelial cells during cancer development and progression is not clear. In present study the biological effects of VEGF, VEGF-rich culture medium of peritoneal macrophages from mice with Lewis lung carcinoma were studied on MAEC cell line under conditions of unfed culture. We have shown that VEGF increased cell proliferation by the 5th day of culturing vs control and anti-VEGF-treated cells. This effect was associated with increased consumption of glucose and NO production by the 2nd day while decreased – on the 5th day of cell culturing. VEGF-mediated NO production was dependent on Ca2+ ions. Block of Ca2+-channels (LaCl3) had more pronounced inhibitory effect vs chelator of Ca2+ ions (EDTA). It was shown that peritoneal macrophages are the main suppliers of VEGF at tumor angiogenesis, as evidenced by the data obtained on model system of endothelial cells synchronized in G0/G1 phase.

1 January 2017 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
VNViktoriia Nikulina
Viktoriia Nikulina
LGLiudmyla V. Garmanchuk
Liudmyla V. Garmanchuk
TNTetiana Nikolaienko
Tetiana Nikolaienko
NSNatalia Senchylo
Natalia Senchylo

1 January 2014 in International Journal of Physiology and Pathophysiology
Verified
Journal Article
Closed access
PDF file
VNVictoria V. Nikulina
Victoria V. Nikulina
LGLiudmyla V. Garmanchuk
Liudmyla V. Garmanchuk
AMAlexandr N. Makarenko
Alexandr N. Makarenko
NKNataliya N. Khranovskaya
Nataliya N. Khranovskaya
TNTetiana V. Nikolaienko
Tetiana V. Nikolaienko
NKNikolay S. Kositsyn
Nikolay S. Kositsyn
The effect of mitocorrectin (complex of native oligopeptides isolated from the brain of newborn pigs) on the endothelial cells in culture was studied. The preparation has been revealed to induce angiogenesis in vitro in a concentration-dependent manner. Based on the results of MTT assay and a standard cell counting in Goryaev chamber, mitogenic effect of mitocorrectin was shown at concentration of 0.1 - 1 mg / ml, which involves an increasey in the number of cells by 25% ± 5%, as well as increased subpopulations of proliferative cell pool (G2 / M + S) 1.8-fold after mitocorrectin dilutions from 0.01 to 0.05 mg / ml, relative to the control value. In 3D-cultured cells and in the stationary growth, effects were fixed which indicate mitocorrectin-induced differentiation of the endothelial cells: reduced NO production, increased metabolism of glucose, and the formation of capillary-like structures.

1 January 2013
Verified
Journal Article
Closed access
LHL V Harmanchuk
L V Harmanchuk
OMOleksandr Makarenko
Oleksandr Makarenko
NKN M Khranovs'ka
N M Khranovs'ka
TNTetiana Nikolaienko
Tetiana Nikolaienko
VNViktoriia Nikulina
Viktoriia Nikulina
MKM S Kositsyn
M S Kositsyn